1. Home
  2. NKTX vs BFIN Comparison

NKTX vs BFIN Comparison

Compare NKTX & BFIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NKTX
  • BFIN
  • Stock Information
  • Founded
  • NKTX 2015
  • BFIN 1924
  • Country
  • NKTX United States
  • BFIN United States
  • Employees
  • NKTX N/A
  • BFIN N/A
  • Industry
  • NKTX Biotechnology: Pharmaceutical Preparations
  • BFIN Savings Institutions
  • Sector
  • NKTX Health Care
  • BFIN Finance
  • Exchange
  • NKTX Nasdaq
  • BFIN Nasdaq
  • Market Cap
  • NKTX 123.5M
  • BFIN 142.4M
  • IPO Year
  • NKTX 2020
  • BFIN N/A
  • Fundamental
  • Price
  • NKTX $1.80
  • BFIN $11.65
  • Analyst Decision
  • NKTX Strong Buy
  • BFIN
  • Analyst Count
  • NKTX 6
  • BFIN 0
  • Target Price
  • NKTX $14.40
  • BFIN N/A
  • AVG Volume (30 Days)
  • NKTX 434.5K
  • BFIN 90.6K
  • Earning Date
  • NKTX 08-12-2025
  • BFIN 07-30-2025
  • Dividend Yield
  • NKTX N/A
  • BFIN 3.36%
  • EPS Growth
  • NKTX N/A
  • BFIN N/A
  • EPS
  • NKTX N/A
  • BFIN 0.36
  • Revenue
  • NKTX N/A
  • BFIN $48,547,000.00
  • Revenue This Year
  • NKTX N/A
  • BFIN N/A
  • Revenue Next Year
  • NKTX N/A
  • BFIN $6.40
  • P/E Ratio
  • NKTX N/A
  • BFIN $33.34
  • Revenue Growth
  • NKTX N/A
  • BFIN N/A
  • 52 Week Low
  • NKTX $1.31
  • BFIN $10.15
  • 52 Week High
  • NKTX $8.23
  • BFIN $13.97
  • Technical
  • Relative Strength Index (RSI)
  • NKTX 51.45
  • BFIN 50.48
  • Support Level
  • NKTX $1.68
  • BFIN $11.61
  • Resistance Level
  • NKTX $1.84
  • BFIN $11.90
  • Average True Range (ATR)
  • NKTX 0.08
  • BFIN 0.28
  • MACD
  • NKTX 0.01
  • BFIN 0.05
  • Stochastic Oscillator
  • NKTX 80.95
  • BFIN 66.67

About NKTX Nkarta Inc.

Nkarta Inc is a clinical-stage biopharmaceutical company pioneering the development of allogeneic, off-the-shelf engineered natural killer (NK) cell therapies. The Company is engaged in leveraging the natural potent power of NK cells to identify and kill abnormal cells and recruit adaptive immune effectors to generate responses that are specific and durable. The company is combining its NK expansion platform technology with proprietary cell engineering technologies to generate an abundant supply of NK cells, engineer enhanced NK cell recognition of therapeutic targets, and improve persistence for sustained activity in the body for the treatment of cancer.

About BFIN BankFinancial Corporation

BankFinancial Corp is a full-service, national bank providing banking, financial planning and fiduciary services to individuals, families and businesses in the Chicago metropolitan area and on a regional or national basis for commercial finance, healthcare finance, equipment finance, commercial real estate finance and treasury management business customers. The Bank offers its customers a broad range of loan, deposit, trust and other financial products and services through approximately 18 full-service banking offices located in Cook, DuPage, Lake and Will Counties, Illinois and through its Internet Branch.

Share on Social Networks: